One Nucleus to Provide More Focused Meetings

One Nucleus, the not-for-profit membership company for international life science and healthcare companies, is launching a series of high level conferences concentrating on specific technology areas, replacing its annual BioPartnering Exchange conference. The move comes in response to member feedback and aims to deliver a more tailored conference experience. Following the merger of ERBI with the London Biotechnology Network in May 2010 to form One Nucleus, feedback from members as well as pharma and investors has indicated that the ‘now generic’ model of membership organisations delivering expensive broad-spectrum

biopartnering conferences is now less fit for purpose. Harriet Fear, CEO of One Nucleus, said: “We feel it is time to leave the larger forums to for-profit organisers, and use the resources to deliver top quality, well focused events that provide debate and deal flow opportunities. Details of dates and venues will be issued shortly with the first in the series in early Summer 2011.